CVE-2026-35637: OpenClaw — HIGH

OpenClaw before 2026.3.22 performs cite expansion before completing channel and DM authorization checks, allowing cite work and content handling prior to final auth decisions. Attackers can exploit this timing vulnerability to access or manipulate content before proper authorization validation...

Full CISO analysis pending enrichment.

What systems are affected?

Package	Ecosystem	Vulnerable Range	Patched
OpenClaw	pip	—	No patch
4 dependents 37% patched ~3d to patch Full package profile →

Do you use OpenClaw? You're affected.

How severe is it?

CVSS 3.1

7.3 / 10

EPSS

N/A

Exploitation Status

No known exploitation

Sophistication

N/A

What is the attack surface?

AV Network

AC Low

PR None

UI None

S Unchanged

C Low

I Low

A Low

What should I do?

No patch available

Monitor for updates. Consider compensating controls or temporary mitigations.

Which compliance frameworks are affected?

Compliance analysis pending. Sign in for full compliance mapping when available.

Frequently Asked Questions

What is CVE-2026-35637?

OpenClaw before 2026.3.22 performs cite expansion before completing channel and DM authorization checks, allowing cite work and content handling prior to final auth decisions. Attackers can exploit this timing vulnerability to access or manipulate content before proper authorization validation occurs.

Is CVE-2026-35637 actively exploited?

No confirmed active exploitation of CVE-2026-35637 has been reported, but organizations should still patch proactively.

How to fix CVE-2026-35637?

No patch is currently available. Monitor vendor advisories for updates.

What is the CVSS score for CVE-2026-35637?

CVE-2026-35637 has a CVSS v3.1 base score of 7.3 (HIGH).

What are the technical details?

Original Advisory

OpenClaw before 2026.3.22 performs cite expansion before completing channel and DM authorization checks, allowing cite work and content handling prior to final auth decisions. Attackers can exploit this timing vulnerability to access or manipulate content before proper authorization validation occurs.

Weaknesses (CWE)

CWE-696 Incorrect Behavior Order

CWE-696 — Incorrect Behavior Order: The product performs multiple related behaviors, but the behaviors are performed in the wrong order in ways that may produce resultant weaknesses.

Source: MITRE CWE corpus.